TheraSonic

Paris, France Founded: 2023 • Age: 3 yrs
Develops medical devices for non-invasive brain drug delivery and barrier disruption.

About TheraSonic

TheraSonic is a Healthcare company based in Paris (France) founded in 2023 by Benoit Larrat. It develops medical devices for non-invasive brain drug delivery and barrier disruption. It operates on a B2B model. Its chief executive is Benoit Larrat. TheraSonic offers products and services including Focused Ultrasound Device. Its focus areas include Medical Devices, Neurology, Drug Delivery and Biotech. Its competitors include Impel NeuroPharma, CraniUS, EyeGate, Cognos Therapeutics and Cordance Medical and 5 more; 7 of its 10 listed competitors have raised funding.

Company details

TheraSonic, based in Paris, focuses on advancing treatments for brain diseases by enabling targeted drug delivery. The company uses non-invasive focused ultrasound to temporarily disrupt the blood-brain barrier, allowing therapeutics to reach specific brain areas. Backed by academic research and a team of experts, it emphasizes safety, accuracy, and innovation in medical devices for neurological disorders.

Products & Services of TheraSonic

TheraSonic offers a comprehensive portfolio of products and services, including Focused Ultrasound Device.

Focused Ultrasound Device
Medical Device

Enables non-invasive drug delivery by disrupting blood-brain barrier.

People of TheraSonic

2 people are tracked at TheraSonic (2 in leadership).

NameRoleGroup
Anthony Novell
Co-founderLeadership
Benoit Larrat
Co-Founder, CEOLeadership
Premium access

Complete people profiles for TheraSonic

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Competitors of TheraSonic

TheraSonic has 10 listed competitors in our database, 7 of them funded. They include Impel NeuroPharma, CraniUS, EyeGate, Cognos Therapeutics and Cordance Medical, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
impelnp.com2008Seattle, United States$126.83M158
Intranasal delivery technology for CNS diseases is developed.
craniustherapeutics.com2021Baltimore, United States$20.5M–
Drug delivery systems for brain diseases and disorders are developed.
eyegatepharma.com1998Waltham, United States$44.47M12
Therapeutics and drug delivery systems for eye diseases are developed.
cognosthx.com2015Los Angeles, United States$5.75M13
Cognos Therapeutics is focused on innovative neurological and oncological treatments.
cordancemedical.com2018Mountain View, United States––
Non-invasive ultrasound device for blood-brain barrier is developed.
flex-grip.com2011Diepenbeek, Belgium$11M2
Catheter cushions and stabilisation devices are provided for patient safety.
passport-tech.com2019San Diego, United States––
Transdermal drug delivery systems are developed using microporation technology.
bionxt.com2018Vancouver, Canada–49
Drug formulations and delivery systems for diseases are developed.
nsgene.dk1999Ballerup, Denmark$5.14M–
Specializes in drug delivery systems and therapeutics for central nervous system diseases.
palyonmedical.com2004New York, United States$24M–
Develops implantable drug delivery systems for central nervous system disorders.
Premium access

Detailed competitors of TheraSonic

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

10 companies that operate in the same segment as TheraSonic (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about TheraSonic

TheraSonic was founded in 2023.

TheraSonic is headquartered in Paris, France.

Benoit Larrat is the current CEO of TheraSonic. They have also founded this company.

TheraSonic, based in Paris, focuses on advancing treatments for brain diseases by enabling targeted drug delivery. The company uses non-invasive focused ultrasound to temporarily disrupt the blood-brain barrier, allowing therapeutics to reach specific brain areas. Backed by academic research and a team of experts, it emphasizes safety, accuracy, and innovation in medical devices for neurological disorders.

TheraSonic's top competitors include Impel NeuroPharma, CraniUS and Cognos Therapeutics.

TheraSonic offers Focused Ultrasound Device.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available